Telehealth Strategies for Lung Cancer Screening
(ITALCS Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Integrating Telehealth to Advance Lung Cancer Screening?
The use of telemedicine in lung cancer screening, particularly through shared decision-making, is being explored to improve screening completion rates. Additionally, successful implementation of lung screening programs in different healthcare systems highlights the potential for telehealth to enhance early detection and treatment of lung cancer.12345
Is telehealth for lung cancer screening safe for humans?
The studies reviewed focus on lung cancer screening using low-dose CT scans, which are generally safe but can have potential harms like false-positive results and procedural complications. However, no major complications were reported in the studies, suggesting that the screening process is generally safe.678910
How does the treatment 'Integrating Telehealth to Advance Lung Cancer Screening' differ from other treatments for lung cancer screening?
This treatment is unique because it uses telehealth to provide counseling, follow-up care, and smoking cessation support remotely, while the actual lung cancer screening is done in-person with a low-dose CT scan. This approach aims to overcome barriers to screening by making it more accessible, especially for underserved populations.45111213
What is the purpose of this trial?
The goal of this pragmatic trial is to learn if telehealth strategies can increase shared decision-making (SDM) for lung cancer screening (LCS). It will also learn about the equity of these strategies by conducting non-inferiority analysis by race and sex. The main questions it aims to answer are:1. Does patient outreach using synchronous and asynchronous telehealth strategies increase completion of SDM visits for LCS?2. Is the effectiveness of these telehealth strategies similar by race and sex?The study uses a Sequential Multiple Assignment Randomized Trial (SMART) design and includes two stages of interventions. The first stage of intervention includes direct patient outreach with an invitation to schedule either a 1) telehealth SDM visit or 2) telehealth or in-person SDM visit. Participants that do not respond to the first stage interventions receive a text message reminder encouraging SDM visit completion with or without digital care coordination.
Research Team
Katharine Rendle, PhD
Principal Investigator
Abramson Cancer Center
Eligibility Criteria
This trial is for individuals who are potential candidates for lung cancer screening. It's not clear what specific inclusion criteria are, but typically participants would be at risk for lung cancer due to factors like age and smoking history. There's no information on exclusion criteria provided.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Stage 1 Intervention
Participants receive outreach to schedule a telehealth or in-person SDM visit
Stage 2 Intervention
Non-responders receive text message reminders and possibly digital care coordination
Follow-up
Participants are monitored for completion of SDM and LDCT, and lung cancer diagnoses
Treatment Details
Interventions
- Integrating Telehealth to Advance Lung Cancer Screening
Find a Clinic Near You
Who Is Running the Clinical Trial?
Abramson Cancer Center at Penn Medicine
Lead Sponsor
National Cancer Institute (NCI)
Collaborator
National Institutes of Health (NIH)
Collaborator